Symposium 213: Tailored Therapies for IBD: A Look into the Future


The aim of this Falk Symposium is to dive into possibilities of personalized medicine for IBD
patients. All speakers and moderators are internationally recognized IBD experts and build the
basis for an up-to-date state-of-the-art symposium on IBD. The program is designed to provide opportunities for ample discussion and interaction with speakers, moderators and attendees.

Preliminary Program:

- Predicting good or bad prognosis

- Conventional therapies: Optimizing therapies to patient profiles

- Anti-TNF: a tailor made Approach

- Vedolizumab and ustekinumab

- New molecules

- Tailoring surgery to patients

- Challenging clinical scenarios

Termine und Preise
05.10. - 06.10.2018
/ Ab 09:00 Uhr
Milano (Italien)
/ Milan Marriott Hotel
Congress Fees
Scientific Program of Symposium 213 € 200,00
Students (copy of student ID required) € 100,00
Day Ticket € 120,00
Students (copy of student ID required) day Ticket € 60,00